P4M3 Gen. 2.0

· Philip Morris Products S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P4M3 Gen. 2.0, covering 2024-03-13 to 2024-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence [NA]

See pricing